Skip to content

3Accepted May 3, 5:07 PM ET

Versant Vantage II, L.P. 3

TPSTTempest Therapeutics, Inc.

Accepted (ET)

5:07 PM

May 3, 2022

Filed

May 3, 2022

Documents

1

Size

9.1 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.